Cassava Sciences Inc vs Paychex, Inc. — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Paychex, Inc. trades at $121.11 (market cap $43.14B). The key difference: Paychex, Inc. is far larger — about 903.5× Cassava Sciences Inc's market cap, and Paychex, Inc. pays a 3.92% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | PAYX | |
|---|---|---|
Market Cap | $47.75M | $43.14B |
Sector | Health | Industrials |
52-Week High | $4.64 | $140.81 |
52-Week Low | $0.87 | $85.57 |
Enterprise Value | -$34.93M | $46.63B |
Dividend Yield | — | 3.92% |
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →